Nonconserved residues in the second transmembrane-spanning domain of the D4 dopamine receptor are molecular determinants of D4-selective pharmacology

Molecular Pharmacology

Volumn 57, Issue 1, 2000, Pages 144-152

  Schetz, John A ^a   Benjamin, Peter S ^a   Sibley, David R ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [[4 (4 IODOPHENYL)PIPERAZIN 1 YL]METHYL] 1H PYRROLO[2,3 B]PYRIDINE; DOPAMINE 4 RECEPTOR; PYRIDINE DERIVATIVE; RACLOPRIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; DRUG RECEPTOR BINDING; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; RAT; RECEPTOR BINDING;

ANIMALS; BINDING SITES; COS CELLS; DOPAMINE ANTAGONISTS; LIGANDS; MEMBRANE PROTEINS; MUTAGENESIS, SITE-DIRECTED; PROTEIN CONFORMATION; PYRIDINES; PYRROLES; RATS; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

EID: 0033982868     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Baldwin JM, Schertler GF and Unger VM (1997) An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. J Mol Biol 272:144-164.
2. 2 chimeric dopamine receptors. Soc Neurosci Abstr 20:525.
3. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
4. 2 dopamine receptor. Biochem Soc Trans 23:S95.
5. Cotte N, Balestre M-N, Phalipou S, Hibert M, Manning M, Barberis C and Mouillac B (1998) Identification of residues responsible for the selective binding of peptide antagonists and agonists in the V2 vasopressin receptor. J Biol Chem 273:29462-29468.
6. 2 receptors. J Neurochem 59:627-635.
7. Elling CE, Thirstrup K, Nielsen SM, Hjorth SA and Schwartz TW (1997) Metal-ion sites as structural and functional probes of helix-helix interactions in 7TM receptors. Ann NY Acad Sci 814:142-151.
8. Fu D, Ballesteros JA, Weinstien H, Chen J and Javitch JA (1996) Residues in the seventh membrane-spanning segment of the dopamine D2 receptor accessible in the binding site crevice. Biochemistry 35:11278-11285.
9. Fukuda K, Terasako K, Kato S and Mori K (1995) Identification of the amino acid residues involved in selective agonist binding in the first extracellular loop of the δ- and μ-opioid receptors. FEBS Lett 373:177-181.
10. Hjorth SA, Thirstrup K, Grandy DK and Schwartz TW (1995) Analysis of selective binding epitopes for the κ-opioid receptor antagonist Nor-binaltorphimine. Mol Pharmacol 47:1089-1094.
11. 2 dopamine receptors by amiloride and amiloride analogues. Mol Pharmacol 50:1295-1308.
12. 1-adrenergic receptor subtype selective agonist binding. J Biol Chem 270:23189-23195.
13. Javitch JA, Ballesteros JA, Chen J, Chiappa V and Simpson MM (1999) Electrostatic and aromatic microdomains within the binding-site crevice of the D2 receptor: Contributions of the second membrane-spanning segment. Biochemistry 38:7961-7968.
14. Javitch JA, Ballesteros JA, Weinstein H and Chen J (1998) A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice. Biochemistry 37:998-1006.
15. Javitch JA, Fu D and Chen J (1995) Residues in the fifth membrane-spanning segment of the dopamine D2 receptor exposed in the binding-site crevice. Biochemistry 34:16433-16439.
16. 2 ligands by their sensitivities to modification of the cysteine exposed in the binding-site crevice. Mol Pharmacol 49:692-698.
17. 2 dopamine receptor is exposed in the binding-site crevice. Proc Natl Acad Sci USA 91:10355-10359.
18. Kerkman DJ, Ackerman M, Artman LD, MacKenzie RG, Johnson MC, Bednarz L, Montana W, Asin KE, Stampfli H and Kebabian JW (1989) A-69024: A non-bezazepine antagonist with selectivity for the dopamine D-1 receptor. Eur J Pharmacol 166:481-491.
19. Kimura Y, Vassylyev DG, Miyazawa A, Kidera A, Matsushima M, Mitsuoka K, Murata K, Hiral T and Fujiyoshi Y (1997) Surface of bacteriorhodopsin revealed by high-resolution electron crystallography. Nature (Lond) 389:203-206.
20. Kobilka B (1992) Adrenergic receptors as models for G protein-coupled receptors. Annu Rev Biochem 15:87-114.
21. Lawler CP, Prioleau C, Lewis MM, Mak C, Jiang D, Schetz JA, Gonzalez AM, Sibley DR and Mailman RB (1999) Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes. Neuropsyckopharmacology 20:612-627.
22. Mailman RB, Nichols DE and Tropsha A (1997) Molecular drug design and dopamine receptors, in The dopamine receptors (Kim A. Neve and Rachel L. Neve eds) pp 105-133, Humana Press, Totowa, New Jersey.
23. 2 receptor. Eur J Pharmacol 227:205-214.
24. Miller DD, Harrold M, Wallace HA and Uretsky NJ (1988) Dopaminergic drugs in the cationic form interact with D2 dopamine receptors. Trends Pharmacol Sci 9:282-284.
25. 5]enkephalin from binding to the δ-opioid receptor. Mol Pharmacol 50:1413-1422.
26. Minami M, Onogi T, Nakagawa T, Katao Y, Aoki Y, Katsumata S and Satoh M (1995) DAMGO, a μ-opioid receptor selective ligand, distinguishes between μ- and κ-opioid receptors at a different region from that for the distinction between μ- and δ-opioid receptors. FEBS Lett 364:23-27.
27. 125I]L-750,667, a novel radioligand for the dopamine D4 receptor. Mol Pharmacol 50:1658-1664.
28. Pollock NJ, Manelli AM, Hutchins CW, Steffey ME, MacKenzie RG and Frail DE (1992) Serine mutations in transmembrane V of the dopamine D1 receptor affect ligand interactions and receptor activation. J Biol Chem 267:17780-17786.
29. 3 receptor antagonist, activates locomotion in rodents. J Pharmacol Exp Ther 275:1239-1246.
30. 2-like dopamine receptors through distinct molecular mechanisms. J Pharmacol Exp Ther 289:956-964.
31. Schetz JA and Sibley DR (1997) Zinc allosterically modulates antagonist binding to cloned D1 and D2 dopamine receptors J Neurochem 68:1990-1997.
32. 4. Neuropsychopharmacology 7:261-284.
33. Strader CD, Fong TM, Tota MR and Underwood D (1994) Structure and function of G protein-coupled receptors. Annu Rev Biochem 63:101-132.
34. Unger VM, Hargrave PA, Baldwin JM and Schertler GFX (1997) Arrangement of rhodopsin transmembrane α-helices. Nature (Lond) 389:203-206.
35. Valiqufstte M, Vu HK, Yue SY, Wahlestedt C and Walker P (1996) Involvement of Trp-284, Val-296 and Val-297 of the human opioid receptor in binding of δ-selective ligands. J Biol Chem 271:18789-18796.
36. 1-adrenergic receptor subtype-selective antagonist binding. Mol Pharmacol 50:1118-1126.